BioVaxys Technology Corp. buy Zitronenlimonade
Start price
30.12.20
/
50%
€0.13
Target price
30.12.21
€5.00
Performance (%)
9.92%
End price
31.12.21
€0.14
Summary
This prediction ended on 31.12.21 with a price of €0.14. With a performance of 9.92%, the BUY prediction by Zitronenlimonade for BioVaxys Technology Corp. closed with a slight gain. Zitronenlimonade has a follow-up prediction for BioVaxys Technology Corp. where he still thinks BioVaxys Technology Corp. is a Buy. Zitronenlimonade has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| BioVaxys Technology Corp. | -3.371% | -3.371% | 190.541% | -74.328% |
| iShares Core DAX® | 4.094% | 4.888% | 17.421% | 22.413% |
| iShares Nasdaq 100 | 1.424% | -0.445% | 37.618% | 58.203% |
| iShares Nikkei 225® | -1.572% | -4.911% | 12.951% | 7.961% |
| iShares S&P 500 | 1.822% | 0.776% | 29.182% | 49.914% |
According to Zitronenlimonade what are the pros and cons of BioVaxys Technology Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Strong uniques
Very Future proof/growth oriented business model
Leading role in innovation
Cons
High risks for its business
Comments by Zitronenlimonade for this prediction
In the thread BioVaxys Technology Corp. diskutieren
The comment has been deleted
Kursziel geändert auf 0,5
Kursziel geändert auf 1,0
Kursziel geändert auf 5,0
In the thread Trading BioVaxys Technology Corp.
Die von Zitronenlimonade gewählte maximale Laufzeit wurde überschritten
Current prediction by Zitronenlimonade for BioVaxys Technology Corp.
BioVaxys Technology Corp.
Start price
Target price
Perf. (%)
€0.026
02.01.24
02.01.24
-
02.07.24
02.07.24
64.12%
10.05.24
10.05.24
Could be very worthwhile Investment >20% year
Strong uniques
Very Future proof/growth oriented business model
Leading role in innovation
